VC
Value Add VC
⚡HomePulse⚡Helpful Apps📝Blog🤝Partner
Illustration for: Bezos-Backed Flourish Raises $500M at $2.5B to Build Brain-Inspired AI Chips
Value Add VC/Pulse/FUNDING$500M

Bezos-Backed Flourish Raises $500M at $2.5B to Build Brain-Inspired AI Chips

Flourish, a New York startup co-founded by Internet Explorer creator and CTRL-labs founder Thomas Reardon, raised $500 million at a $2.5 billion valuation to build brain-inspired AI -- with Jeff Bezos nearly doubling his check to roughly $100 million. Its 'Cortex AI' aims to map real neurons and run models at laptop-level power, attacking AI's energy crisis at the architecture level.

By the Numbers

$500M
Raised
$2.5B
Valuation
~$100M
Bezos Check
Lux, GV, Catalio
Backers
20-50 watts
Power Target
TC
Trace Cohen
Early-stage VC & angel · Founder, New York Venture Partners
June 6, 2026
1 min read
ShareXLinkedInEmail

THE RUNDOWN

1

A $500M seed-stage bet on brain-inspired computing shows investors hunting for a way around AI's power wall

2

Bezos personally writing ~$100M signals conviction that energy, not scale, is the binding constraint

3

Reardon's CTRL-labs and connectomics pedigree gives a wild thesis real technical credibility

4

20-50 watt model inference would upend the data-center economics underpinning today's AI

TC

The VC Read · Trace's Take

Trace Cohen

A $500M check into pre-product brain-inspired computing is a bet that AI's real wall isn't intelligence, it's watts -- and that's a thesis I think is underrated. Bezos doubling his stake personally tells you smart money sees the energy crisis as the constraint that scaling can't solve. The pedigree (IE, CTRL-labs, an Amazon S-team exec) is what separates this from a science-fair pitch. The risk is obvious -- connectomics is hard and timelines are long -- so size it like a call option, but if it works the data-center math inverts.

💰 Funding Tracker →⚡ AI Chip Wars →

Analysis

Flourish raised $500 million at a $2.5 billion valuation to pursue brain-inspired AI, with Jeff Bezos writing one of the biggest checks -- initially around $50 million before nearly doubling to roughly $100 million. Lux Capital, GV and Catalio Capital also backed the round, which came together in about five weeks after discussions began in late April.

The company is building what it calls Cortex AI, a system designed to emulate brain function by mapping real neurons and their connections -- the field of connectomics. The headline ambition is efficiency: Flourish targets inference in the 20-to-50-watt range, roughly a laptop's draw rather than a server rack's, a direct assault on the energy economics that increasingly constrain AI's expansion.

“The company is building what it calls Cortex AI, a system designed to emulate brain function by mapping real neurons and their connections -- the field of connectomics.”

The founding team gives the moonshot weight. Thomas Reardon created Internet Explorer at Microsoft and later founded the brain-computer-interface company CTRL-labs, which Meta acquired in 2019 for an estimated $1 billion; co-founder Rob Williams is a former Amazon S-team executive. It's a contrarian bet that the next leap in AI comes from rethinking the substrate, not just scaling the current one.

ShareXLinkedInEmail

More on

Flourish →

Reported by TechFundingNews · Analysis by Value Add Pulse.

← Back to Pulse

THE WIRE in your inbox— Tech, startup & VC news with Trace's take. Free, no spam.

Read Next

FUNDING· Aug 4, 2026

Valar Atomics Triples to $6B for Factory Nuclear

Illustration for: Valar Atomics Triples to $6B for Factory Nuclear
FUNDING$1B Series B

Valar Atomics Triples to $6B for Factory Nuclear

Valar Atomics raised a $1B Series B led by Sequoia at a $6B valuation, tripling its mark since April, months after using a fission reaction to power an Nvidia chip for the first time.

FUNDING· Aug 4, 2026

Obsidian Security Raises $85M, Crosses $1.1B Value

Illustration for: Obsidian Security Raises $85M, Crosses $1.1B Value
FUNDING$85M Series D

Obsidian Security Raises $85M, Crosses $1.1B Value

Obsidian Security raised an $85M Series D led by Crescent Cove Advisors at a $1.1B valuation, becoming a unicorn on demand for securing AI agents and non-human identities inside enterprises.

FUNDING· Aug 4, 2026

QuantHealth Raises $45M to Simulate Drug Trials

Illustration for: QuantHealth Raises $45M to Simulate Drug Trials
FUNDING$45M Series B

QuantHealth Raises $45M to Simulate Drug Trials

QuantHealth raised a $45M Series B led by Qumra Capital to expand AI simulation of clinical trials before patients enroll, a platform already used by 12 of the world's top 20 pharma companies.

@Trace_Cohen·t@nyvp.com